News
We recently published a list of 13 Most Profitable Growth Stocks to Buy Now. In this article, we are going to take a look at ...
The growth factor in investing refers to companies that grow their revenue and earnings at rates significantly above the ...
4d
Zacks Investment Research on MSNPfizer Q1 Earnings Beat Estimates, Several Headwinds Hurt SalesPfizer PFE reported first-quarter 2025 adjusted earnings per share of 92 cents, which comprehensively beat the Zacks ...
Zai Lab (ZLAB) announced that China’s National Medical Products Administration has accepted the supplemental new drug application for ...
LONDON and BOSTON, April 10, 2025 (GLOBE NEWSWIRE) -- Ottimo Pharma (“Ottimo”), an innovative biotech company developing one-of-a-kind PD-1/VEGFR2 dual paratopic antibodies to extend the lives ...
Dansey, a former senior executive at Pfizer and Seagen, Inc., brings extensive experience in immuno-oncology and drug development Board appointment reinforces Company's commitment to advancing ...
Myricx Bio Announces Expansion of its Leadership Team to Advance NMTi-ADCs into Clinical Development
including Darzalex ® and Tivdak ® an ADC marketed for the treatment of cervical cancer. Dr. Lisby holds a Doctor of Medical Science (D.MSc.) and M.D. from the University of Copenhagen.
Myricx Bio Announces Expansion of its Leadership Team to Advance NMTi-ADCs into Clinical Development
including Darzalex ® and Tivdak ® an ADC marketed for the treatment of cervical cancer. Dr. Lisby holds a Doctor of Medical Science (D.MSc.) and M.D. from the University of Copenhagen. Robin Carr Ph.D ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results